Response to "Reply to: 'The decreasing predictive power of MELD in an era of changing etiology of liver disease'"

被引：0
|
作者：
Godfrey, Elizabeth L. [1 ]
Malik, Tahir H. [1 ]
Lai, Jennifer C. [2 ]
Mindikoglu, Ayse L. [1 ,3 ]
Galvan, N. Thao N. [1 ]
Cotton, Ronald T. [1 ]
O'Mahony, Christine A. [1 ]
Goss, John A. [1 ]
Rana, Abbas [1 ]
机构：
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Abdominal Transplantat, Houston, TX 77030 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Baylor Coll Med, Margaret M & Albert B Alkek Dept Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷 / 03期
关键词：
classification systems; Model for End-Stage Liver Disease (MELD); clinical research; practice; health services and outcomes research; liver transplantation; hepatology; organ allocation; organ procurement and allocation; patient survival; registry; registry analysis; waitlist management; MODEL; SURVIVAL;
D O I：
10.1111/ajt.15783
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：903 / 904
页数：2
相关论文
共 50 条
  • [21] THE CHANGING FACE OF SIMULTANEOUS LIVER AND KIDNEY TRANSPLANTATION IN THE SHARE 35 AND MELD-NA ERA: INCREASED TRANSPLANT ACCESS AND LIVER DEPENDENT OUTCOMES
    Fung, Phoenix
    Northup, Patrick G.
    GASTROENTEROLOGY, 2018, 154 (06) : S1100 - S1100
  • [22] CYSTATIN C IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS, BUT DOES NOT IMPROVE THE PREDICTIVE POWER OF MELD
    Finkenstedt, A.
    Dorn, L.
    Griesmacher, A.
    Prokop, W.
    Graziadei, I.
    Vogel, W.
    Zoller, H.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S68 - S68
  • [23] OUTCOMES OF WAIT-LISTED LIVER TRANSPLANT (LT) CANDIDATES WITH CHRONIC LIVER DISEASE (CLD) IN THE UNITED STATES: THE IMPACT OF MODEL OF END STAGE LIVER DISEASE (MELD) SCORES AND DISEASE ETIOLOGY
    Stepanova, Maria
    de Avila, Leyla
    Morgan, Amanda
    Sayiner, Mehmet
    Erario, Madeline
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2017, 152 (05) : S1131 - S1131
  • [24] POST-LIVER TRANSPLANTATION RENAL DYSFUNCTION PRIMARILY DRIVEN BY OLDER AGE AND MELD AT LISTING RATHER THAN LIVER DISEASE ETIOLOGY TYPE
    Wadhwa, Niki
    Houston, Kevin
    Khan, Hiba
    Alroobi, Hasan
    Chadha, Nikita
    Spencer, Chad
    Sterling, Richard
    Asgharpour, Amon
    Keller, Nicole
    Wedd, Joel
    Lee, Hannah
    Siddiqui, Mohammad
    Patel, Vaishali
    Aseem, Sayed Obaidullah
    Kumaran, Vinay
    Lee, Seung
    Sharma, Amit
    Khan, Aamir
    Imai, Daisuke
    Levy, Marlon
    Bruno, David
    HEPATOLOGY, 2024, 80 : S1032 - S1033
  • [25] PREDICTIVE POWER OF CLINICAL STIGMATA IN DETECTING ADVANCED LIVER DISEASE
    Bloom, S. D.
    Kemp, W.
    Dev, A.
    Nicoll, A.
    Roberts, S.
    Bell, S.
    Kronborg, I.
    Knight, V.
    Sood, S.
    Lubel, J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S289 - S289
  • [26] MELD 3.0: AN UPDATED VERSION OF THE MODEL FOR END-STAGE LIVER DISEASE TO OPTIMIZE WAITLIST OUTCOMES IN THE MODERN ERA
    Kim, W. Ray
    Mannalithara, Ajitha
    Kamath, Patrick S.
    Heimbach, Julie
    Asrani, Sumeet K.
    Biggins, Scott W.
    Kwong, Allison J.
    HEPATOLOGY, 2020, 72 : 824A - 824A
  • [27] Predictive Roles of Gut Dysbiosis on the Severity of Nonalcoholic Fatty Liver Disease Reply
    Boursier, Jerome
    Barret, Matthieu
    Diehl, Anna Mae
    HEPATOLOGY, 2016, 64 (03) : 994 - 995
  • [28] SURVIVAL AFTER ORTHOTOPIC LIVER TRANSPLANTATION (OLT) FOR HCV CIRRHOSIS HAS NOT IMPROVED IN THE MODEL FOR END-STAGE LIVER DISEASE (MELD) ERA
    Becker, Natasha S.
    Vierling, John M.
    Sussman, Norman L.
    Stribling, Rise
    O'Mahony, Christine A.
    Goss, John A.
    Jalal, Prasun K.
    HEPATOLOGY, 2008, 48 (04) : 585A - 585A
  • [29] Diagnostic Power of Fibroscan in Predicting Liver Fibrosis in Nonalcoholic Fatty Liver Disease Reply
    Wong, Vincent Wai-Sun
    Vergniol, Julien
    Chan, Henry Lik-Yuen
    de Ledinghen, Victor
    HEPATOLOGY, 2009, 50 (06) : 2049 - 2050
  • [30] Acute liver failure in patients with terminal heart failure undergoing mechanical bridging: the predictive value of the Model-of-End-stage_Liver-Disease (MELD)
    Hoefer, J.
    Ulmer, H.
    Kilo, J.
    Velik-Salchner, C.
    Lorenz, I.
    Margreiter, R.
    Mair, P.
    Ruttmann-Ulmer, E.
    EUROPEAN HEART JOURNAL, 2013, 34 : 946 - 946
12345